Published in Physician Law Weekly, March 1st, 2006
The newly granted patent, EP1105529B1, adds to Solexa's intellectual property (IP) portfolio of some of the earliest and most fundamental patents and applications addressing the use of both single molecules and amplified colonies of single molecules for genetic analysis applications, including DNA sequencing and gene expression analysis.
EP1105529B1 covers devices comprising arrays of single molecules including polynucleotides, methods for producing the devices, and their subsequent use. An example...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly